European Healthcare Innovation Leadership Network
Redefining value and innovation in healthcare
The European Healthcare Innovation Leadership Network is focused on advancing European healthcare innovation that addresses unmet needs and ensures patient access to valuable treatments in an era of severe budgetary pressures.
The network brings together public and private sector European healthcare leaders committed to improving patient well-being. Members include public and private sector leaders who represent regulators, health technology assessors (HTA), healthcare budget holders, patient representatives, civil society, and medicine developers. The network is supported by AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, and Johnson & Johnson.
Recently, the network began piloting a new way for diverse stakeholders to engage critical questions about medicines in development, enabling health systems to provide the right medicines to the right patients at the right time. As these pilots move forward, the network will continue to address critical emerging issues in healthcare.
Recent network topics:
